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 There is incredible diversity amongst eukaryotic tissues and overall body plans. 
Changes in individual cell shapes are essential for generating higher levels of complexity 
through morphogenetic events. Various molecular mechanisms are responsible for 
driving cell shape changes during development under tight spatial and temporal 
regulation. Apical constriction is a process by which cells shrink their apical surfaces 
through actomyosin contractions to orchestrate tissue-bending events including 
vertebrate neural tube formation and gastrulation. C. elegans is a valuable system for 
studying mechanisms that drive apical constriction in vivo, including how one endodermal 
cell fate-specifying transcription factor, END-3, drives apical constriction of two 
endodermal cells, thus beginning gastrulation of the embryo. Here, we screened for new 
gastrulation genes from among genes regulated by END-3 using RNAi and identified 7 
new candidate END-3 targets that contribute to gastrulation. We predict that some of 
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CHAPTER 1: INVESTIGATION OF THE MOLECULAR MECHANISMS  
LINKING CELL-FATE SPECIFICATION AND SHAPE CHANGE IN  




Apical constriction is a process that drives tissue morphogenesis during metazoan 
development. In apical constriction, epithelial cells alter their shapes by constricting just 
the apical side of the cell. This simple change can remodel entire tissues and sculpt 
various organs including the gut and, in vertebrates, the neural tube1 (Figure 1). During 
vertebrate embryonic development, neurulation is driven by apical constriction2. It is 
through neurulation that the neural tube—which will subsequently become the brain and 
spinal cord—is formed. In mammals, improper or incomplete neurulation can lead to birth 
defects such as spina bifida, a neural tube defect that occurs in approximately 1 per 1,000 
births worldwide3. While some prenatal therapeutic treatments against neural tube defects 
have emerged4, and many efforts have been made to understand the mechanisms of 
apical constriction5, there are still several central questions that remain unresolved 
surrounding the mechanistic details. 
Apical constriction is driven by contractions of the actomyosin cortex, an expansive 
intracellular network of the actin cytoskeleton and the motor protein non-muscle myosin 
II. These contractions generate tension at the cellular level that is transmitted across the 
epithelial layer through cell-cell junctions1. Focused along the apical surfaces of 
neighboring cells, the generated tension acts as a pulling force to shrink the apical 
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surface, often forming wedge-shaped cells that together orchestrate tissue folding and 
invagination6 (Figure 2A).  
The nematode Caenorhabditis elegans has proven to be a valuable system for 
understanding the mechanistic details of cell shape change during apical constriction in 
vivo. In C. elegans, gastrulation begins with the internalization of two endodermal 
precursor cells (EPCs)7. These two cells are born on the surface of the embryo, change 
shape through apical constriction, and move inwards towards the center of the embryo 
until their surfaces are fully covered by neighboring cells (Figure 2B). We note that 
“apical” is defined differently across biological systems; in the C. elegans embryo, “apical” 
refers to the outer (exposed) cell surface facing the vitelline envelope, while “basolateral” 
refers to surfaces that are in contact with adjacent cells. 
This process is developmentally coordinated and extremely consistent; apical 
constriction occurs in the same cells with predictable timing across embryos. Individual 
cells can be identified due to the fact that asymmetry in the C. elegans embryo is initiated 
at fertilization, with the anteroposterior axis being specified by the point of sperm entry8. 
Beginning from the one-cell stage, many subsequent divisions of the early embryo are 
asymmetric and characteristic, such that cell identity and lineage can easily be tracked9.  
Additionally, C. elegans is easily amenable to both genetic and cellular 
manipulations, and its transparent appearance facilitates subcellular live imaging. The 
genetic tractability of C. elegans permits direct mutagenesis and the creation of 
endogenous fluorescent protein fusions10,11. C. elegans also has rapid development: the 
entire embryonic development of these organisms occurs in 12 hours12. These 
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characteristics make C. elegans an extremely useful system for studying apical 
constriction in vivo in a rapid and reproducible manner. 
In the C. elegans embryo, gastrulation begins at the 26- to 28-cell stage with the 
apical constriction and internalization of the two EPCs. These two cells, termed Ea and 
Ep (for E-anterior and E-posterior), originate at the surface of the embryo when born from 
their mother E cell progenitor. During apical constriction, these two cells shrink their 
exposed apical surfaces and internalize into the center of the embryo until their entire 
apical surface is covered by neighboring cells13. For simplicity, we use “gastrulation” in 
this work to refer only to the internalization of Ea and Ep; although, to complete 
gastrulation in its entirety, this is later followed by internalization of precursor cells of 
muscle, germline, and other lineages9. 
Previous experiments done by our lab and others have characterized in detail the 
processes of apical constriction and gastrulation in C. elegans. In the internalizing EPCs, 
cell fate specification and apical constriction appear to be tightly coordinated processes. 
Within C. elegans, endodermal cell fate is specified by the combined action of two partially 
redundant, endoderm-specific GATA-type transcription factors, END-1 and END-314,15. In 
the absence of these factors, embryos do not specify endoderm and do not form a gut, 
ultimately resulting in either embryonic or larval lethality15,16. Recent studies have also 
shown that apical constriction in the E cells occurs via the activation of apically-localized 
myosin through the myosin kinase MRCK-1, another protein required for apical 
constriction and gastrulation of these cells17. In embryos deficient for END-1 and END-3, 
or deficient for END-3 alone, Ea and Ep do not apically constrict and do not recruit MRCK-
1 to the apical surface17. Thus, in addition to directly specifying endodermal fate, it 
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appears that these partially-redundant endodermal GATA factors somehow also 
contribute to apical constriction, though their role in this mechanism remains incompletely 
understood. The primary goal of this research has been to understand by what 
mechanism END-3 orchestrates apical constriction in the endodermal precursors of the 
developing C. elegans embryo, as a model for how cell fate regulates morphogenesis 
more generally. 
 Genetic redundancy is a prevalent complication in studying the morphogenetic 
events that drive development18. The roles of partially or entirely redundant genes are 
often difficult to detect using traditional, single-knockdown screening techniques; the loss 
of one gene can be rescued by its redundant counterpart, thereby potentially masking 
any defect19. The partial redundancy of end-1 and end-3 in C. elegans endoderm 
specification has been shown previously14,15, so it stands to reason that several redundant 
genes may have a role in orchestrating apical constriction downstream of these factors. 
 One method for overcoming redundancy is using sensitized genetic backgrounds 
to enhance or expose phenotypes of interest. By screening in mutant backgrounds, it is 
possible to discover phenotypes that do not emerge with single mutagenesis or deletion15. 
This technique has been used previously in C. elegans to elucidate redundant genes 
implicated in vulval and pharyngeal formation20, as well as gastrulation15,20. 
We hypothesize that END-3 orchestrates apical constriction and gastrulation of the 
endodermal precursor cells in C. elegans by regulating the transcription of one or several 
genes that control either new or known cellular mechanisms that contribute to cell shape 
change and cell positioning. We utilized targeted knockdown of top candidate END-3 
targets via RNA interference (RNAi) to screen for gastrulation defects in both wild-type 
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and sensitized backgrounds. We report the identification of 7 new genes encoding 
proteins with nonredundant or partially redundant functions in E cell gastrulation. Although 
these proteins are largely uncharacterized to date, they seem to suggest cell signaling as 
an important process downstream of E cell specification. These data provide promising 
new candidates for elucidating mechanistic details connecting cell fate specification and 
shape change in C. elegans and perhaps more broadly across metazoans, as well. 
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Experimental Approach and Methods 
C. elegans strains and maintenance 
Worms were cultured and handled as previously described21. Experiments were 
performed using the following worm strains: N2, wild type; VC271, end-1 (ok558); 
FX02295, sdz-19 (tm2295). Worms were maintained at 20°C. 
dsRNA synthesis 
Double-stranded RNAs (dsRNAs) were prepared and synthesized as previously 
described22. dsRNAs were synthesized for 21 genes, targeting the entire protein-coding 
region excluding introns, generated from cDNA. Synthesized dsRNA size and 
concentration were verified using gel electrophoresis and Nanodrop spectrophotometry, 
respectively. dsRNAs were stored at -20°C in aliquots either at the original or diluted 1 
µg/µL concentration. Aliquots were thawed before use. No aliquots were thawed and 
refrozen more than once, to maintain dsRNA integrity. 
RNA interference injections 
RNA interference (RNAi) was performed by injecting dsRNA at a concentration of 
1 µg/µL* into the bodies of young adult worms, either into the gut or gonad. Injected 
worms were moved to new plates seeded with OP50 bacteria to recover at 20°C and 
incubated for 24-48 hours before embryos were imaged. [*For some constructs, a slightly 
lower concentration was injected due to a smaller dsRNA yield] 
Embryonic lethality assays 
Following RNAi injections, 3-5 worms were moved to a single recovery plate 
seeded with OP50 bacteria. Following 24 hours of incubation at 20°C, all living adult 
worms from one plate were transferred to a new recovery plate and all dead worms were 
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removed. This was repeated for all replicate plates per dsRNA genotype. Living worms 
were transferred at 24, 48, and 72 hours post injection, allowing for 24 hours of embryo 
laying on each new plate.  
Plates were scored twice after transferring all living adult worms to a new plate: (1) 
24 and (2) 48 hours after adult worms began laying embryos, i.e., at 0 and 24 hours after 
the last embryos were laid onto the plate. By 48 hours, all embryos should have hatched 
when incubated at 20°C. For (1), the total number of embryos and any already hatched 
larvae were counted. For (2), the total number of unhatched embryos (any remaining 
embryos) were counted. Unfertilized oocytes were excluded from calculations. For each 
individual plate of 3-5 injected worms, “% Embryonic Lethality” was calculated as a 
percentage of (2) / (1).  
Mounting embryos for imaging 
Embryos were mounted laterally, as described previously17. Embryos were 
dissected from gravid adult worms, and embryos at the 1-6 cell stage were transferred 
into a droplet of Egg Buffer (118 mM NaCl, 40 mM KCl, 3.4 mM CaCl2, 3.4 mM MgCl2, 
and 5 mM HEPES [pH 7.2]) on a coverslip coated with poly-L lysine. Coverslips were 
mounted onto glass slides with 2.5% agarose pads and sealed with VALAP wax (equal 
parts petroleum jelly, lanolin, and paraffin). Imaging was performed at 20-23°C. 
Microscopy 
Differential interference contrast (DIC) microscopy images were acquired with a 
Diagnostic Instruments SPOT2 camera mounted on a Nikon Eclipse 800 microscope. 
Embryos were filmed under DIC illumination using Z-stacks of 1 µm steps through the 




Determining candidate END-3 targets as regulators of gastrulation 
 
 The central goal of this research has been to determine the role of genes that are 
controlled directly or indirectly by END-3. Because END-3 is a transcription factor, we 
hypothesized that it transcriptionally regulates a gene or genes to orchestrate apical 
constriction in endoderm precursor cells. To identify genes regulated directly or indirectly 
by END-3, previous members of our lab performed RNA sequencing (RNA-seq) and 
transcriptome profiling of C. elegans embryos at the early E2 stage (containing 2 EPCs) 
in both wild-type N2 and an end-3 deletion background (SC Tintori, unpublished)5. These 
experiments gave us reads per kilobase of transcript, per million mapped reads (RPKM) 
values indicating transcript abundance of genes from whole embryos.  
 We aimed to identify genes that are both (1) regulated directly or indirectly by END-
3, and (2) expressed specifically in the early E lineage before these cells internalize. To 
determine candidates most likely to be regulated by END-3, we ordered the transcript 
abundance data described above by the ratio of expression in end-3 (ok558) over 
expression in N2 (WT), such that the genes with the lowest ratio indicated those most 
down-regulated in end-3 mutants. In other words, END-3 likely directly or indirectly 
regulates the expression of these genes. These “candidate END-3 targets” are thus 
defined as being genes whose mRNA levels decrease in an end-3 deletion line. 
Additionally, we determined which genes were highly and specifically expressed 
in the E cell and/or its daughter cells, Ea and Ep, using an online tool previously 
developed by our lab23. These analyses demonstrated that 24 of the top 26 genes most 
regulated by END-3 activity had high transcript abundance in Ea/Ep as compared with 
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the rest of the 16-stage embryo (Figure 3). This returned a list of genes both positively 
regulated by END-3 and with abundant transcript levels in the EPCs, representing 
promising candidate regulators of gastrulation to investigate further. 
Depleting candidate END-3 targets gives minimal rates of embryonic lethality 
 Following the selection of the top 24 potential END-3 targets, we sought to 
determine the role of these genes in apical constriction and gastrulation. Previous studies 
have shown that 95% of embryos from an end-3 genetic null strain fail to gastrulate at the 
correct time, although there is only a 6% rate of embryonic lethality, because the 
endodermal precursors typically do eventually internalize24. 
We hypothesized that any gene(s) regulated by END-3 during apical constriction 
and gastrulation would give a phenotype similar to that seen in an end-3 genetic null 
background—namely, embryonic lethality rates no higher than 6% but a high level of 
gastrulation defects (although, if a candidate also functioned in other necessary 
processes, depletion could result in a much higher level of lethality). To test this 
hypothesis, we first synthesized double-stranded RNAs (dsRNAs) to target specific genes 
by RNA interference (RNAi). We generated dsRNAs targeting 17 of the top 24 genes from 
our prioritized list. We then assayed for embryonic lethality following RNA injections by 
quantifying laid embryos that failed to hatch.  
For wild-type N2 worms, we observed an average of 2.21% (C.I. -1.25 – 5.67%) 
embryonic lethality after 48 hours of laying. We found that for all 17/17 genes targeted, 
RNAi injection resulted in low rates of lethality not significantly different from those seen 
for WT (Figure 4). As a positive control, we injected dsRNA against gdi-1, which encodes 
a Rab GDP dissociation inhibitor (GDI) with characterized embryonic lethality upon 
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targeting by RNAi25. We observed an average lethality of 38.6% (C.I. 14.1 – 63.0%) after 
48 hours and 87.9% (C.I. 64.1 – 111.6%) after 72 hours, thereby validating our 
experimental technique. Only knockdown of one gene, T19B10.2, resulted in an initially 
apparent increased rate of 12.2% (C.I. 0.33 – 24.0%) embryonic lethality, which was not 
statistically significant using a 95% confidence interval.    
Visualizing gastrulation in vivo following targeted knockdown implicates candidate  
END-3 targets in gastrulation 
 Previous studies have shown that end-3 null embryos have low levels of embryonic 
lethality but very high levels of gastrulation defects, including delayed but eventual 
internalization of endodermal precursor cells24. To determine whether our targeted genes 
displayed similar phenotypes, we chose to directly visualize gastrulation following the 
targeting of genes by RNAi. During wild-type development, division of one cell of the 4-
cell stage embryo gives rise to the endodermal and mesodermal precursor cells (E and 
MS cells). These two cells in turn divide to give rise to two E daughter cells (Ea/Ep) and 
two MS daughter cells (MSa/MSp, referred to together as MSx here). Ea and Ep then 
internalize into the center of the embryo before dividing again once fully internalized, such 
that no part of any of the 4 EPCs is exposed on the surface.  
 To screen for gastrulation defective (Gad) phenotypes, we performed RNAi in a 
wild-type (N2) background to knock down 12 candidate END-3 targets and visualized 
gastrulation using DIC microscopy. We chose the MSx cell division as a consistent 
beginning time point for comparing timing across embryos, as any EPC gastrulation 
defects would not be expected to affect MSx division timing, although it may affect division 
timings of the E or E2 cells (Ea/Ep). In wild-type embryos, the E2 cells internalized in 17.0 
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(C.I. 14.9 – 19.1) minutes following the MSx cell division. These E2 cells, once fully 
internalized, then divided an average of 3.7 (C.I. 1.6 – 5.8) minutes later.  
For some candidates targeted by RNAi, we observed Gad phenotypes in which 
either or both E2 cells did not fully internalize before dividing. Of the 12 candidate END-
3 targets screened, we found that 5 showed 0% Gad phenotypes (n = 6-24 embryos per 
target), while 7 displayed Gad phenotypes, ranging from 5.9 – 38.5% penetrance (Table 
1). The majority of these candidates encode uncharacterized, worm-specific proteins with 
predicted signal peptides (F14H12.6, T19B10.2, T22D1.11), 5-pass transmembrane 
domains (F19C6.5), or possible mitochondrial function (T25G12.2). The remaining 2 
candidates have been characterized as encoding proteins involved in RAS signaling (dve-
1) or sphingolipid metabolism (asm-1), with known homologs in Drosophila and humans, 
respectively26. 
To further characterize the Gad phenotypes of these 7 candidates, we also 
measured gastrulation timing in these embryos. Across RNAi genotypes, all Gad embryos 
were characterized by late internalization: either one or both E2 cell was still exposed 
upon division, but all E4 daughters were fully covered by neighboring cells before dividing 
again. The severity of this delay varied across different RNAi targets, ranging from 3 
minutes (F19C6.5) to 14 minutes (T25G12.2) following the E2 division. In contrast, the 
time between the MSx and E2 division remained consistent between embryos exhibiting 
Gad and non-Gad phenotypes, suggesting that the observed Gad phenotypes are not 
due to alterations in cell cycle timing, as occurs in some other mutants25, or likely in cell 
fate more generally. Together, these data implicate 7 new genes in E cell internalization. 
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Targeted knockdown in sensitized backgrounds 
 Because genetic redundancy is prevalent throughout morphogenetic events in C. 
elegans24, including endoderm specification and gastrulation15, and for morphogenesis 
more generally18, we hypothesized that END-3 regulates apical constriction through 
genes that are partially or entirely redundant. To test this hypothesis, we chose to 
continue screening for gastrulation defects in two sensitized backgrounds: (1) end-1 
(ok558) deletion, and (2) sdz-19 (tm2295) deletion. As mentioned previously, end-1 
encodes endoderm-specifying END-1, a transcription factor partially redundant with END-
314. We hypothesized that by targeting END-3 candidates and not END-3 itself, we could 
identify genes involved in gastrulation while bypassing defects in endoderm specification 
(as seen following loss of both end-1 and end-3)15. On the other hand, sdz-19 encodes 
an uncharacterized protein that has been previously implicated in gastrulation24.  
 We first wanted to determine whether targeting candidate END-3 targets with RNAi 
in these two sensitized backgrounds increased rates of embryonic lethality for any gene. 
I mentored a first-year graduate student as she addressed this question using RNAi by 
feeding against top candidate END-3 targets in the two sensitized background strains, 
end-1 and sdz-19. RNAi by feeding in C. elegans is a quick and easy way to screen 
through a list of genes, although this technique can be variable or ineffective27. With this 
in mind, we selectively only looked for targets whose knockdown resulted in greatly 
increased rates of embryonic lethality. This screen gave us 3 candidates with embryonic 
lethality rates greater than 30%: F19C6.5, F14H12.6, and ppt-1 (J Robinson, 
unpublished; data not shown). 
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  We next sought to determine whether the apparent increase in embryonic lethality 
in targeted knockdown of these 3 candidates was accompanied by gastrulation defects. 
We performed RNAi by injection against these candidates in both end-1 and sdz-19 
backgrounds and imaged the embryos of injected worms. We found that in the un-injected 
end-1 deletion strain, 100% of embryos showed Gad phenotypes, with Ea/Ep internalizing 
an average of 47 (C.I. 43.6 – 50.4) minutes following the MSx division (Figure 5, Table 
1). Targeted knockdown of all 3 candidates in the end-1 deletion background also showed 
100% Gad phenotypes, as expected. For F19C6.5 and F14H12.6, we also observed a 
clear increase in the time required for internalization in some embryos, with maximum 
internalization times of 102 minutes and 75 minutes, respectively.  
In embryos from the un-injected sdz-19 deletion strain, we observed 16.7% Gad 
phenotypes, with an average internalization time of 23 (C.I. 16.9 – 19.1) minutes following 
the MSx division (Figure 5, Table 1). All three knockdown targets showed significant 
increases in Gad phenotype incidence, ranging from 20 – 42.9%. No targeted candidate 
displayed any significant change in internalization timing. 
We observed that RNAi of ppt-1 did not result in gastrulation defects in a wild-type 
background and did not enhance the Gad phenotypes observed in both end-1 and sdz-
19 deletion backgrounds. From this, we conclude that that ppt-1 likely does not play an 
important role in E cell gastrulation. However, for both F19C6.5 and F14H12.6, we 
observed that targeting by RNAi resulted in Gad phenotypes in wild type, as well as an 
increase in internalization timing in sensitized backgrounds. We conclude that F19C6.5 
and F14H12.6 remain strong candidates of interest as potential regulators of gastrulation, 
along with the other 5 candidates identified through screening in wild type.   
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Discussion 
 Apical constriction is a critical morphogenetic event employed throughout 
development to generate a variety of tissue shapes and structures6,28. C. elegans offers 
a chance to link cell fate specification to the intracellular behaviors that drive this process: 
the transcription factor END-3 is required for both endoderm fate specification and 
gastrulation17,24. Here, we found that loss of 7 new candidate END-3 targets also resulted 
in gastrulation defects, implicating them as having an important role in gastrulation. 
 Our first method of screening through top candidate END-3 targets by assaying for 
embryonic lethality following RNAi by injection gave no significant results. This is not 
surprising for two main reasons. First, it has previously been shown that even when END-
3 has been depleted in a wild-type background, there is only a 6% rate of embryonic 
lethality24. Even if we hypothesize that END-3 interacts with only 1 downstream target 
that mediates all of END-3’s essential functions, the maximum rate we expect to see 
would be 6%, a rate that may not emerge as significant based on our statistical analysis. 
Second, we have no reason to believe that END-3 is interacting with only 1 target gene 
that mediates all of END-3’s essential functions. Genetic redundancy is prevalent 
throughout biological systems and processes, including in C. elegans gastrulation14,15, 
and particularly so for morphogenesis18. Endoderm is specified by the concerted actions 
of END-1 and END-329, and even apical constriction itself relies on redundant cell-cell 
junction proteins30. For these reasons, we decided to directly image embryos to expose 
non-lethal gastrulation defects, as seen following end-3 deletion24. 
 Direct injection of dsRNAs targeted against top candidate END-3 targets into adult 
worms followed by in vivo imaging yielded 7 E cell-specific genes whose depletion 
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affected gastrulation. All of these genes are newly identified as potential regulators of 
gastrulation and had not emerged in previous screening attempts24. Of these genes, 5 
encode proteins that appear to be both worm-specific and uncharacterized: F19C6.5, 
T25G12.2, F14H12.6, T19B10.2, and T22D1.11. One gene, dve-1, encodes three 
proteins (through alternative splicing) with a COMPASS (CMP) domain and has been 
shown to genetically interact with at least two components of the EGF/RAS signaling 
pathway31. The CMP domain of DVE-1 (Defective proVEntriculus-1, from Drosophila) also 
appears to be homologous to the CMP domain of homeodomain proteins, such as human 
SATB1, and Drosophila DVE32. Finally, asm-1 encodes a sphingomyelin 
phosphodiesterase33 and appears to be conserved in many organisms, including humans; 
loss of the human homologs of asm-1 results in Niemann-Pick disease, a lipid storage 
disorder cause by a buildup of lipids within cells and tissues34,35. Asm-1 also appears to 
have a role in apoptosis in various systems36. Previous studies have implicated other 
genes in both apoptosis and gastrulation in C. elegans, as well5. This could potentially 
suggest that the EPCs internalize through activating part of the apoptotic pathway and 
inducing neighboring cells to produce actin-rich extensions required for internalization of 
the EPCs37. 
 We also used sensitized backgrounds in our screen to attempt to overcome 
genetic redundancy among regulators of gastrulation. Surprisingly, we saw that 100% of 
embryos from our end-1 deletion strain expressed Gad phenotypes, in contrast to 
previous reports24 (Figure 5, Table 1). This is similar to the reported phenotype for a 
deletion of end-3 alone24 and suggests that END-1 also has a role in regulating 
expression of genes important for gastrulation. However, these data could also indicate 
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that the end-1 (ok558) deletion strain used has picked up a confounding background 
mutation. We suggest that future users outcross this strain to remove any background 
mutations or recreate it using CRISPR/Cas9 methods11.  
With a baseline level of 100% Gad phenotypes in end-1, we could not assay for 
increased rate of Gad, but we did see delayed internalization timing following knockdown 
of F19C6.5 and F14H12.6, further implicating these proteins as regulators of gastrulation. 
Knockdown of F19C6.5 (but not F14H12.6) in an sdz-19 background also showed 
increased internalization defects. This could imply that both F19C6.5 and F14H12.6 
regulate gastrulation. We note that for all genes here implicated to have a role in 
gastrulation, we cannot be sure whether these genes contribute to apical constriction 
specifically or endoderm specification without further testing. 
 Apical constriction is a process that occurs to drive a variety of morphogenetic 
movements across biological systems6. With such diversity surrounding this process, one 
fundamental question is how developmental patterning regulates the force-producing 
machinery required to orchestrate cell shape change in the right cells at the right time. To 
do this, it seems that all metazoans that employ apical constriction must have 
mechanisms in place to spatially and temporally define which cells will constrict, polarize 
constricting cells (such that only one surface constricts), and initiate the force-generating 
machinery that will mechanically constrict the cell(s).  
 Although some mechanistic details of apical constriction have been elucidated in 
various systems, including Drosophila38, C. elegans6, and Xenopus39, it remains unclear 
how conserved aspects of apical constriction are across metazoans—does fate 
specification regulate apical constriction through similar mechanisms and homologous 
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proteins? The identification of 7 proteins as potentially having important roles in 
gastrulation offers the possibility to uncover more of the mechanistic details. This could 
ultimately help us to identify commonalities across biological systems, evolutionary 
innovation within C. elegans, and/or mechanistic details not previously recognized but 
broadly used in other systems. 
 Of the 7 candidates we identified, 5 appear to be worm-specific and 
uncharacterized, with essentially nothing known about their functions. Based on protein 
domain predictions, 2 of these appear to have transmembrane domains (TMD) and 3 
have predicted signal peptide domains (Table 1). Almost half of the genes in the C. 
elegans genome encode proteins with a signal peptide, a transmembrane domain, or 
both, meaning that a substantial number of proteins within C. elegans are localized to 
membranes or are secreted40. Of the genes identified here, one or all of these proteins 
may play a role in inter- or intracellular signaling to ultimately help orchestrate apical 
constriction, through myosin activation or modulating the inter- or intracellular force 
context in which cortical tension can produce changes in cell shape. 
 Studies of apical constriction in Drosophila have elucidated many mechanistic 
details about the link between cell fate specification and apical constriction38. In 
Drosophila, the mesodermal progenitors undergo apical constriction and internalization. 
Mesodermal fate is determined by a maternal transcription factor Dorsal; Dorsal then 
activates transcription factors Snail and Twist. Previous studies have shown that loss of 
Snail and Twist prevents apical constriction in these cells, and loss of the Twist target 
protein Folded Gastrulation (Fog) results in failed apical constriction, as well41. Fog itself 
is a secreted protein, and loss of downstream signaling proteins—including Ga and 
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transmembrane proteins—also results in gastrulation defects42,43. Although some of our 
identified candidates appear to be uncharacterized and worm specific, it seems 
interesting to consider that parallels might exist between these proteins and known 




 The screens described here have provided us with a short list of promising END-3 
targets with roles in gastrulation; the next steps require characterizing these new proteins 
and assessing whether expression patterns and functions continue to implicate these 
proteins as regulators of gastrulation. We also aim to understand the mechanism of apical 
constriction in vivo in C. elegans, the specific role END-3 plays, and broadly, how 
conserved this mechanism may be with those employed by other organisms, including 
Drosophila and mammals. 
 One of the first future experiments will be to continue to verify the results explained 
here. In both lethality experiments (Figure 4) and imaging for gastrulation defects 
(Figures 5,6), we had small sample numbers for several genes targeted by RNAi. 
Especially for the genes that gave Gad phenotypes upon targeting, repeating these 
experiments will give us a better and more reliable idea of the rate of observing Gad 
phenotypes, which may help to prioritize genes for subsequent experiments. 
 To characterize these newly-identified proteins, we first want to know where these 
proteins are localized. To do this, we will observe subcellular protein localization in vivo 
during development. Our lab has previously generated robust methods for doing this, by 
using the CRISPR/Cas9 system to generate endogenous fluorescent protein fusions10,11. 
By generating worm strains each with one fluorescently-tagged gene from the 7 identified 
here, we can then use fluorescence microscopy during embryonic development to assess 
whether these proteins are enriched apically, basolaterally, or at cell junctions. We can 
hypothesize that proteins with apical enrichment might contribute to increasing cortical 
tension before constriction17, whereas proteins being apically secreted may alter the 
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extracellular force context against which apical shrinking forces may act44. Alternatively, 
proteins with junctional localization may contribute to the molecular clutch hypothesized 
to coordinate intracellular actomyosin contractions to apical constriction28. 
 Upon determining localization patterns and timing, we will then further characterize 
the candidates’ roles in apical constriction. Previous experiments have shown that prior 
to apical constriction in C. elegans, myosin must be activated by the kinase MRCK-1, 
which localizes to the apical surface17. To determine whether these candidates affect 
apical constriction through localizing MRCK-1, we will use targeted knockdown of 
candidates in a worm strain with fluorescently-labeled MRCK-1 or myosin. We expect that 
if a candidate directly regulates apical constriction, knockdown of the candidate will result 
in a reduction of apically-localized MRCK-1 followed by a lack of apical constriction and 
late (or failed) internalization of the E cells. These experiments could be performed in 
sensitized strains, as well, to overcome any masked, redundant phenotypes. 
 Another interesting question to address in the future is whether END-3 alone is 
sufficient to orchestrate apical constriction. This can be tested by ectopically expressing 
END-3 in other cells of the early embryo. This is complicated by the fact that END-3 is an 
endodermal fate-specifying transcription factor; however, by expressing END-3 in an 
already-specified lineage, such as the mesodermal lineage (MS cells), we could hope to 
avert these complications. If END-3 is sufficient, we could expect that ectopic END-3 
expression induces apical constriction and upstream events such as MRCK-1 localization 
with timings similar to those observed in the E cells. If END-3 does appear to be sufficient 
for apical constriction, this will suggest to us that all of the factors necessary are present 
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more broadly than in just the E cells, and that direct regulation of even just one gene could 
trigger the entire process.  
 Ultimately, we aim to understand broad mechanisms of apical constriction by 
expanding our studies to other cells and tissues. Within C. elegans, after the E cells 
internalize, mesodermal and germline precursor cells also internalize into the center of 
the embryo, some by apical constriction7. Within sets of internalizing MS cells, some cells 
internalize more quickly than others; within 4 cells of C lineage (neuron, epidermis, and 
muscle precursors) cells, progeny of 2 cells internalize while progeny of 2 others do not9. 
We hypothesize that although these lineages are specified through different mechanisms, 
they all act through similar proteins to orchestrate apical constriction. Previous 
experiments and preliminary analysis of single-cell transcriptome data have implicated a 
family of LIM domain-containing junctional proteins as candidates for having a regulatory 
role in gastrulation: members of this family have increased expression in gastrulating E 
and MS cells (SC Tintori, unpublished). Other members in our lab are further 
characterizing the roles of these proteins using RNAi knockdown and targeted 
mutagenesis to screen for gastrulation defects in one or several cell lineages (MM 
Slabodnick, unpublished). These experiments will allow us to better understand the kinds 
of proteins being utilized in apical constriction across lineages, which will shed light on 
what may be some of the most broadly used, and possibly conserved, factors within this 
iterative morphogenetic event. 
 Together, these experiments will further elucidate specific proteins and 
mechanisms deployed by cells to orchestrate apical constriction in a spatially- and 
temporally-regulated manner. C. elegans is an important system for studying the detailed 
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mechanisms involved in apical constriction across various cell lineages and can help to 
reveal key factors in these processes. By comparing these results with known 
mechanistic details across species such as Drosophila and Xenopus, we can begin to 
understand which mechanistic details are conserved, which have redundant functions but 
through various factors, and which are innovations by a specific organism or tissue. These 
data will help us better understand the connection between cell specification and the 
morphogenetic events required for proper animal development across metazoans.  
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MS div. à 
E intern. 
(min) 
MS div. à 




Control --- N2 (wild type) 2.2 ± 3.5 17.0 ± 1.6 20.7 ± 1.3 
0 
(0/16) 
F19C6.5 5-pass TMD N2 (wild type) 1.0 ± 1.2 18.0 ± 1.4 21.0 ± 0.8 14.3 (3/21) 
C29F7.2 kinase-like domains N2 (wild type) --- 18.0 + 1.4 22.7 ± 1.4 0 (0/10) 
nlp-31 
neuropeptide-like 
proteins N2 (wild type) 3.3 ± 6.3 18.8 ± 1.1 23.5 ± 2.2 
0  
(0/6) 
ugt-23 hexosyl group transferase N2 (wild type) 0.9 ± 0.9 18.6 ± 1.0 21.7 ± 0.7 
0 
(0/7) 
T25G12.2 mitochondrial function N2 (wild type) 0.6 ± 0.6 21.8 ± 3.4 22.5 ± 1.0 
27.3 
(3/11) 
C26F1.1 extracellular signal peptide domain N2 (wild type) 0.7 ± 0.7 18.1 ± 0.7 21.8 ± 1.0 
0 
(0/16) 
dve-1 CMP domain,  RAS signaling N2 (wild type) 1.8 ± 1.4 18.8 ± 2.4 23.0 ± 1.3 
9.1 
(1/11) 
asm-1 sphingomyelin phosphodiesterase N2 (wild type) 1.0 ± 0.5 24.5 ± 3.8 22.1 ± 0.9 
38.5 
(5/13) 
F14H12.6 signal peptide,  1-pass TMD N2 (wild type) 5.0 ± 4.2 19.9 ± 2.2 22.8 ± 1.2 
5.9 
(1/17) 
ZK185.2 Mg2+ transport N2 (wild type) 0.6 ± 0.6 --- --- --- 
T19B10.2 extracellular signal peptide domain N2 (wild type) 12.2 ± 11.8 21.5 ± 3.8 23.8 ± 1.6 
12.5 
(1/8) 
dpy-14 collagen development N2 (wild type) 1.7 ± 1.2 --- --- --- 
T25G12.1 (uncharacterized) N2 (wild type) 0.4 ± 0.4 --- --- --- 





N2 (wild type) 4.6 ± 9.0 --- --- --- 





N2 (wild type) 0.60 ± 0.5 21.2 ± 3.2 23.4 ± 2.0 
16.7 
(1/6) 
















MS div. à 
E intern. 
(min) 
MS div. à 






(ok558) --- 47 ± 3.4 14.9 ± 1.2 
100 
(9/9) 
F19C6.5 5-pass TMD end-1 
(ok558) --- 56.1 ± 8.8 14.1 ± 0.6 
100 
(15/15) 
F14H12.6 signal peptide,  1-pass TMD 
end-1 













(tm2295) --- 23 ± 6.1 22.5 ± 1.4 
16.7 
(1/6) 
F19C6.5 5-pass TMD sdz-19 
(tm2295) --- 23.2 ± 3.4 20.5 ± 0.8 
38.9 
(7/18) 
F14H12.6 signal peptide,  1-pass TMD 
sdz-19 
(tm2295) --- 25.3 ± 6.3 23.6 ± 1.0 
20 
(2/10) 
ppt-1 palmitoyl protein degradation 
sdz-19 




Table 1 – Results of RNAi screens. The “RNAi Target” column gives the gene name or 
Sequence ID for each targeted gene. Three genetic backgrounds were used for these 
experiments: N2 wild type; end-1 (ok558), a deletion of endoderm-specifying factor END-
1; and sdz-19 (tm2295), a deletion of sdz-19, encoding a protein previously implicated in 
gastrulation24. “% Embryonic Lethality” displays the average lethality seen at 48 hpi (see 
Figure 4). “MS div. à E intern.” displays the average length of time between the MSa/MSp 
division and when both Ea/Ep are fully internalized. “MS div. à E div.” displays the 
average length of time between MSa/MSp division and Ea/Ep division. “% Gad” refers to 
how many of the dsRNA-treated embryos displayed gastrulation defective phenotypes. ± 





APPENDIX 2: FIGURES 
  
 
Figure 1. Apical constriction is a conserved developmental process in C. elegans 
gastrulation and vertebrate neural tube formation. The cells highlighted in green 
are the endodermal precursor cells (EPCs) in C. elegans (left) and neural plate cells in 
vertebrates (right). These cells undergo actomyosin-driven apical constriction (red), to 






















Figure 2. C. elegans embryos orchestrate gastrulation of endodermal precursors 
through apical constriction. (A) Apically-localized networks of actin filaments and 
myosin motor protein are attached to apical cell-cell junctions (AJs). This network 
generates tension that pulls on and shrinks the apical surface. Adapted from Martin and 
Goldstein, 2014. (B) A ventral view of a gastrulation-stage C. elegans embryo. 
Endodermal precursors (Ea, anterior; Ep, posterior) are pseudo-colored in green. These 
cells undergo apical constriction, shrink their exposed surfaces, and fully internalize until 




Figure 3. Top candidate genes are regulated by END-3 and display high transcript 
abundance specifically in E2 cells. Data is shown for 95 of the 100 genes most 
downregulated in end-3 deletion vs. in wild type. Log2(fold change) demonstrates the 
localized transcript abundance of each transcript, where values greater than 0 indicate 
abundance enriched in E2 cells. Genes colored red indicate the top 24 candidate targets 







Figure 4. Embryonic lethality rates observed following RNAi by injection. 
Embryonic lethality was assessed at 24, 48, and 72 hours post injection (hpi) of adult 
worms to control for RNAi efficacy over time. Points indicate mean lethality, with 95% 
confidence intervals plotted. The dotted black line designates 0% lethality for ease of 
comparison. For each dsRNA, 2-12 replicates were performed, with each plate ranging 
in embryo count from 5 to over 500. The N2 wild-type strain indicates baseline lethality 
levels. By 72 hpi, adult worms have greatly decreased fecundity, giving smaller numbers 
of embryos and thus more variable lethality results. For this reason, average embryonic 





Figure 5. Timing of E cell internalization following RNAi knockdown of candidate 
END-3 targets in wild type and sensitized backgrounds end-1 (ok558) and sdz-19 
(tm2295). For each background or targeted knockdown, both the timing of Ex 
internalization (red, left) and Ex division (blue, right) is displayed. The MSx division is 
used as an easily observable developmental landmark for comparisons across embryos. 
N2 = WT strain. Both end-1 (ok558) and sdz-19 (tm2295) are deletion strains that act as 







Figure 6. Targeting by RNAi reveals gastrulation defective (Gad) phenotypes, 
implicating 7 new candidates as regulators of gastrulation. Embryos were imaged 
using DIC microscopy 24 hours post injection of dsRNA targeted towards one gene (listed 
to the left). E cells are outlined in black and pseudo-colored green. Images are from single 
representative embryos displaying Gad phenotypes; individual time points were chosen 
at MSx division (0 mins), and 10, 20, and 30 minutes following the MSx division. In N2 
(wild type), the E cells are fully internalized by 20 minutes and have divided by 30. 
Embryos were mounted laterally, but some Gad phenotypes (in dve-1, T25G12.2, asm-
1, and F14H12.6) are visible only at the embryonic surface, pictured. White arrowheads 
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